MBX Biosciences Income Statement (2023-2026) | MBX

Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 9.07M7.73M11.05M14.40M16.75M15.22M22.41M17.72M19.27M19.76M18.47M
Selling, General & Administrative (Quarter) 1.87M2.26M2.27M2.26M2.87M3.39M4.12M4.08M4.66M6.04M8.79M
Other Operating Expenses (Quarter) -12.03M-15.20M-18.25M-25.05M-20.12M-21.58M
Operating Expenses (Quarter) 10.95M9.99M1.29M1.46M19.61M0.36M1.48M1.69M2.35M25.80M27.27M
Operating Income (Quarter) -10.95M-9.99M-13.31M-16.66M-19.61M-18.61M-26.53M-21.80M-23.93M-25.80M-27.27M
EBIT (Quarter) -10.95M-9.99M-13.31M-16.66M-19.61M-18.61M-26.53M-21.80M-23.93M-25.80M-27.27M
Non-operating items
Interest & Investment Income (Quarter) 0.78M1.15M0.98M0.80M1.47M3.02M2.65M2.39M2.31M3.73M3.75M
Net income details
EBT (Quarter) -10.16M-8.84M-12.34M-15.86M-18.14M-15.59M-23.88M-19.41M-21.62M-22.06M-23.52M
Profit After Tax (Quarter) -10.16M-8.84M-12.34M-15.86M-18.14M-15.56M-23.88M-19.41M-21.62M-22.09M-23.50M
Income from Continuing Operations (Quarter) -10.16M-8.84M-12.34M-15.86M-18.14M-15.59M-23.88M-19.41M-21.62M-22.06M-23.52M
Consolidated Net Income (Quarter) -10.16M-8.84M-12.34M-15.86M-18.14M-15.59M-23.88M-19.41M-21.62M-22.06M-23.52M
Income towards Parent Company (Quarter) -10.16M-8.84M-12.34M-15.86M-18.14M-15.59M-23.88M-19.41M-21.62M-22.06M-23.52M
Net Income towards Common Stockholders (Quarter) -10.16M-8.84M-12.34M-15.86M-18.14M-15.59M-23.88M-19.41M-21.62M-22.06M-23.52M
Additional items
EPS (Basic) (Quarter) -9.40-7.68-10.26-12.62-2.789.60-0.71-0.58-0.63-0.45-0.50
EPS (Weighted Average and Diluted) (Quarter) -9.40-7.68-10.26-12.62-2.789.60-0.71-0.58-0.63-0.45-0.50
Shares Outstanding (Weighted Average) (Quarter) 1.08M1.02M1.20M1.23M6.52M10.64M33.41M33.45M33.69M36.51M46.58M
Shares Outstanding (Diluted Average) (Quarter) 1.08M1.02M1.20M1.26M3.00M10.64M33.41M33.45M33.69M36.51M46.58M
EBITDA (Quarter) -10.15M-8.79M-12.40M-15.87M-18.02M-15.64M-23.88M-19.45M-21.48M-21.93M-24.41M
Shares Outstanding (Quarter) 1.25M1.26M1.29M1.32M33.38M33.42M33.42M33.59M44.72M44.93M47.57M